Octreotide infusion as a treatment for hepatic hydrothorax in a hospital-at-home program: case report from Mayo Clinic
Hepatic hydrothorax (HH) is a rare but serious complication of end-stage liver disease that is often refractory to conventional medical and procedural management. This case report describes a 75-year-old woman with HH secondary to cirrhosis from metabolic-associated steatotic liver disease. Her clin...
Saved in:
| Main Authors: | Igor Dumic, Margaret R. Paulson, Michael J. Maniaci, Leah W. Webster, Corey Wachter, Andrew Turunen, Charles W. Nordstrom |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/17562848251362573 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic Hydrothorax: The Conundrum and the Oxymoron
by: Sachin Kumar, et al.
Published: (2017-04-01) -
Octreotide Infusion for the Treatment of Congenital Chylothorax
by: Sumayyah Ahmed Nezar Kobeisy, et al.
Published: (2020-01-01) -
Hepatic Hydrothorax without Any Evidence of Ascites
by: Vikram Doraiswamy, et al.
Published: (2011-01-01) -
Hepatic artery pseudoaneurysm–the Mayo Clinic experience and literature review
by: Tatjana Gavrancic, et al.
Published: (2024-12-01) -
85-Year-Old Postsurgical Complex Patient Successfully Managed Remotely at the Novel Mayo Clinic’s Hospital at Home
by: Margaret R. Paulson, et al.
Published: (2022-01-01)